MedQualis   Report issue

For profit Phase 2 Phase 3
Founded: Mount Royal Canada (1992)

Organization Overview

First Clinical Trial
2015
NCT02492022
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

MedQualis

Active Ingredients

Drugs in Phase 3 Trials (2)

cannabidiol (Epidiolex) (1 trial)

tetrahydrocannabinol (1 trial)

Drugs in Phase 2 Trials (1)

probiotic (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cachexia (Phase 3)

Neoplasms (Phase 3)

Substance Withdrawal Syndrome (Phase 2)

Wasting Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3